IGFBP3 and type 2 diabetes mellitus: Recent work on the TMEM219-IGFBP3 axis illustrates this perfectly; the ligand IGFBP3, markedly elevated in sera from both T1D and T2D patients, triggers beta-cell apoptosis by activating its cognate death receptor TMEM219.